Literature DB >> 30620253

Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.

Ji Hye Min1, Young Kon Kim1, Seo-Youn Choi1, Tae Wook Kang1, Soon Jin Lee1, Jong Man Kim1, Soohyun Ahn1, Hyun Cho1.   

Abstract

Purpose To identify whether arterial enhancement pattern at MRI could predict the prognosis after surgical resection of intrahepatic mass-forming cholangiocarcinoma (IMCC). Materials and Methods Patients who underwent curative hepatic resection and preoperative MRI for IMCC from November 2007 to September 2016 were retrospectively evaluated. MRI enhancement pattern was classified by two radiologists. Recurrence and death data were retrieved until September 31, 2017. Prognostic factor analysis was performed by using preoperative and postoperative clinical-pathologic factors, as well as imaging findings. Results Data in 134 patients (median age, 63.0 years; 87 men and 47 women) were evaluated; median tumor size was 4.5 cm. Arterial phase MRI showed diffuse hypoenhancement in 33 patients, peripheral rim enhancement in 81 patients, and diffuse hyperenhancement in 20 patients. The 5-year risk of death in patients with IMCC with diffuse hyperenhancement was lower than that of patients with diffuse hypoenhancement or peripheral rim enhancement (5-year risk of death: 5.9% vs 87.9% vs 59.2%). Diffuse hypoenhancement (hazard ratio [HR], 41; 95% confidence interval [CI]: 5, 312; P < .01) and peripheral rim enhancement (HR, 11; 95% CI: 2, 85; P = .02) were associated with an increased risk of death compared with diffuse hyperenhancement. Patients with diffuse hyperenhancement of IMCCs had more frequent chronic liver disease (13 of 20; 65%), less frequent vascular invasion (six of 20; 30%), and less frequent tumor necrosis (three of 20; 15%) than other enhancement group (P < .05 for all). Conclusion The MRI arterial enhancement pattern was a prognostic marker in the preoperative evaluation of patients with resectable intrahepatic mass-forming cholangiocarcinoma. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Yoon and Lee .

Entities:  

Year:  2019        PMID: 30620253     DOI: 10.1148/radiol.2018181485

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma.

Authors:  Elena Panettieri; Harufumi Maki; Bradford J Kim; HyunSeon Christine Kang; Veronica Cox; Eduardo A Vega; Takashi Mizuno; Shubham Pant; Milind Javle; Jean-Nicolas Vauthey; Yoshikuni Kawaguchi
Journal:  Surg Oncol       Date:  2021-12-31       Impact factor: 3.279

2.  Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).

Authors:  Kai-Pu Jin; Rou-Fan Sheng; Chun Yang; Meng-Su Zeng
Journal:  Abdom Radiol (NY)       Date:  2021-11-25

3.  Subtype Classification of Intrahepatic Cholangiocarcinoma Using Liver MR Imaging Features and Its Prognostic Value.

Authors:  Sungeun Park; Youngeun Lee; Haeryoung Kim; Mi Hye Yu; Eun Sun Lee; Jeong Hee Yoon; Ijin Joo; Jeong Min Lee
Journal:  Liver Cancer       Date:  2022-03-30       Impact factor: 12.430

4.  Diffusion-weighted imaging as an imaging biomarker for assessing survival of patients with intrahepatic mass-forming cholangiocarcinoma.

Authors:  Julaluck Promsorn; Kulyada Eurboonyanun; Payia Chadbunchachai; Chaiwat Apivatanasiri; Kosin Wirasorn; Jarin Chindaprasirt; Aumkhae Sookprasert; Mukesh Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2022-06-15

5.  Values of MRI Imaging Presentations in the Hepatobiliary Phase, DWI and T2WI Sequences in Predicting Pathological Grades of Intrahepatic Mass-Forming Cholangiocarcinoma.

Authors:  Li-Hong Xing; Li-Yong Zhuo; Jia-Ning Wang; Yan Zhang; Feng-Ying Zhu; Chu Wang; Xiao-Ping Yin; Bu-Lang Gao
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

Review 6.  Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Authors:  Mohammed Saleh; Mayur Virarkar; Vlad Bura; Raul Valenzuela; Sanaz Javadi; Janio Szklaruk; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2020-11

7.  Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.

Authors:  Taek Chung; Hyungjin Rhee; Hyo Sup Shim; Jeong Eun Yoo; Gi Hong Choi; Haeryoung Kim; Young Nyun Park
Journal:  Gut Liver       Date:  2021-11-23       Impact factor: 4.321

8.  Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.

Authors:  Michael J King; Stefanie Hectors; Karen M Lee; Olamide Omidele; James S Babb; Myron Schwartz; Parissa Tabrizian; Bachir Taouli; Sara Lewis
Journal:  Cancer Imaging       Date:  2020-07-03       Impact factor: 3.909

9.  DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy.

Authors:  Dong Kuang; Xuemei Hu; Yang Yang; Xianlun Zou; Wei Zhou; Guanjie Yuan; Daoyu Hu; Yaqi Shen; Qingguo Xie; Qingpeng Zhang; Zhen Li
Journal:  Insights Imaging       Date:  2022-03-04

10.  A Case Report of Cholangiocarcinoma Arising from a Biliary Adenofibroma: Radiologic Findings and Review of Literature.

Authors:  Hyun-Ji Lim; Mi-Suk Park; Young Nyun Park; Sun Il Kim; Yeo-Eun Kim; Cheong Hoon Hwang
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.